Significant Events 2001-2005
Sale of Paco (contract manufacturing) – November 2001
New management team – April 2002
Restructuring; Mexico investment; sale of OTC Research Services Group – October 2002
Kinston explosion – January 2003
Kinston restart – January 2004
2-for-1 stock split – September 2004
Drug delivery exit – December 2004
Accelerated capital investment – 2002-04
Acquisition of Monarch Laboratories – February 2005